BBA
EDIT icon

Baader Bank Aktiengesellschaft’s Editas Medicine EDIT Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,545
Closed -$31.2K – 493
2025
Q3 		$31.2K Buy
+14,545
New +$40.6K ﹤0.01% 461

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Baader Bank Aktiengesellschaft's EDIT Position: Q4 2025 in Review

Baader Bank Aktiengesellschaft sold out of Editas Medicine (EDIT) in Q4 2025, closing a stake of 14,545 shares — an estimated $31.2K sold.

Baader Bank Aktiengesellschaft first reported a position in EDIT in Q3 2025 and held it in 1 quarter. The position peaked at $31.2K in Q3 2025. 197 funds tracked by Wall St. Rank hold EDIT as of Q4 2025.

  • Baader Bank Aktiengesellschaft reported no remaining Editas Medicine position as of Q4 2025 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 14,545 Editas Medicine shares in Q4 2025, an estimated $31.2K.
  • Baader Bank Aktiengesellschaft first reported a position in Editas Medicine in Q3 2025 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Editas Medicine position peaked at $31.2K in Q3 2025.
  • 197 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2025, filed 5 Feb 2026.